Advancing Biologics Dry-Powder Inhalation: Challenges and Solutions
Time: 10:30 am
day: Day 1
Details:
- Exploring the integration of monoclonal antibodies, vaccines, and therapeutic proteins into Dry Powder Inhalers (DPIs), assessing their suitability and potential benefits for targeted pulmonary delivery
- Delving into advanced spray drying technologies that optimize the formulation of biologics in DPIs, focusing on maintaining therapeutic integrity and bioactivity
- Examining methods to enhance the stability of biologic formulations in DPIs, preventing protein aggregation to ensure consistent and effective drug delivery
